LEVENT KÜÇÜK, Burçin KEÇECİ, DÜNDAR SABAH, Güven YÜCETÜRK

Aggressive fibromatosis: evaluation of prognostic factors and outcomes of surgical treatment

Objective: The aim of this study was to evaluate the results of surgical treatment of aggressive fibromatosis and the effects of prognostic factors on recurrence. Methods: Forty patients (24 female, 16 male; average age: 31.2 years) diagnosed with aggressive fibromatosis were evaluated retrospectively. Nine patients with tumor-positive surgical margins macroscopically were excluded. Prognostic factors such as age, gender, localization, admission status, compartment status, surgical margin, tumor size and adjuvant radiotherapy were evaluated. Results: Recurrence rate was 29%. Average disease free survival was 46±4 months. There was no statistically significant relation between prognostic factors and recurrence. Clinical results of the patients receiving adjuvant radiotherapy were more satisfactory. Conclusion: Adjuvant radiotherapy administration appears to be a rational treatment method instead of sacrificing function to achieve wide surgical margins.

___

1. Dalén BP, Bergh PM, Gunterberg BU. Desmoid tumors: a clinical review of 30 patients with more than 20 years follow-up. Acta Orthop Scand 2003;74:455-9.

2. Yücetürk G, Sabah D, Keçeci B, Kara AD, Yalçinkaya S. Prevalence of bone and soft tissue tumors. Acta Orthop Traumatol Turc 2011;45:135-43.

3. Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 1997;39:659-65.

4. Hoffmann W, Weidmann B, Schmidberger H, Niederle N, Seeber S, Bamberg M. The clinical picture and therapy of aggressive fibromatosis (desmoids). [Article in German] Strahlenther Onkol 1993;169:235-41. [Abstract]

5. Kirschner MJ, Sauer R. The role of radiotherapy in the treatment of desmoid tumors. Strahlenther Onkol 1993;169:77-82.

6. Nakada I, Ubukata H, Goto Y, Watanabe Y, Sato S, Tabuchi T, et al. Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis. J Gastroenterol 1997;32:255-9.

7. Sørensen A, Keller J, Nielsen OS, Jensen OM. Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand 2002;73:213-9.

8. Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol. 2010;102:380-4.

9. Pajares B, Torres E, Jiménez B, Sevilla I, Rodríguez A, Rico JM, et al. Multimodal treatment of desmoid tumours: the significance of local control. Clin Transl Oncol 2011;13:189-93.

10. Ozger H, Eralp L, Toker B, Ağaoğlu F, Dizdar Y. Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors. Acta Orthop Traumatol Turc 2007;41:291-4.

11. Barbier O, Anract P, Pluot E, Larouserie F, Sailhan F, Babinet A, et al. Primary or recurring extra-abdominal desmoid fibromatosis: assessment of treatment by observation only. Orthop Traumatol Surg Res 2010;96:884-9.

12. Shields CJ, Winter DC, Kirwan WO, Redmond HP. Desmoid tumours. Eur J Surg Oncol 2001;27:701-6.

13. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17:158-67.

14. Goy BW, Lee SP, Fu YS, Selch MT, Eilber F. Treatment results of unresected or partially resected desmoid tumors. Am J Clin Oncol 1998;21:584-90.

15. Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 1999;86:2045-52.

16. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT 3rd. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer 2000;88:1517-23.

17. Rutenberg MS, Indelicato DJ, Knapik JA, Lagmay JP, Morris C, Zlotecki RA, et al. External-beam radiotherapy for pediatric and young adult desmoid tumors. Pediatr Blood Cancer 2011;57:435-42.

18. McKinnon JG, Neifeld JP, Kay S, Parker GA, Foster WC, Lawrence W Jr. Management of desmoid tumors. Surg Gynecol Obstet 1989;169:104-6.

19. Posner MC, Shiu MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF. The desmoid tumor. Not a benign disease. Arch Surg 1989;124:191-6.

20. Pritchard DJ, Nascimento AG, Petersen IA. Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am 1996;78:848-54.

21. Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist 2011;16:682-93.

22. Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR, Ben-Josef E. Role of radiotherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 2011;80:787-92.

23. Meazza C, Bisogno G, Gronchi A, Fiore M, Cecchetto G, Alaggio R, et al. Aggressive fibromatosis in children and adolescents: the Italian experience. Cancer 2010;116:233- 40.

24. Kamath SS, Parsons JT, Marcus RB, Zlotecki RA, Scarborough MT. Radiotherapy for local control of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 1996;36:325-8.

25. McCollough WM, Parsons JT, van der Griend R, Enneking WF, Heare T. Radiation therapy for aggressive fibromatosis. The Experience at the University of Florida. J Bone Joint Surg Am 1991;73:717-25.

26. Plukker JT, van Oort I, Vermey A, Molenaar I, Hoekstra HJ, Panders AK, et al. Aggressive fibromatosis (nonfamilial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg 1995;82:510-4.

27. Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 1998;40:637-45.